News That Matters

Tag: Dewpoint Therapeutics

Dewpoint Therapeutics Granted Second Breakthrough Condensates Platform Technology Patent by US Patent Office
Technology

Dewpoint Therapeutics Granted Second Breakthrough Condensates Platform Technology Patent by US Patent Office

Patent advances Dewpoint's leadership in the discovery of biomolecular condensate modulators with vast potential to treat diseases New technology is the first to measure how a compound is entering or partitioning into a condensate to selectively target a single molecule to alter disease BOSTON, Nov. 14, 2022 /PRNewswire/ -- Dewpoint Therapeutics Inc. today announced the U.S. Patent and Trademark Office (USPTO) issued the patent "Methods of Characterizing Condensate-Associated Characteristics of Compounds and Uses Thereof" (U.S. Patent No. 11493519) covering novel technology for partitioning and identifying compounds which preferentially partition into condensates of interest. Biomolecular condensates are molecular assemblies that form by a process called phase separation, similar to ...